Nucleosil 300 C8 5µm, 250 x 4.6 , HPLC Column

The Nucleosil 300 C8 5µm, 250 x 4.6 , HPLC Column is available to order from Picolab Technologies, serving pharmaceutical and life-science laboratories nationwide. It is manufactured by VDS optilab, a trusted name in laboratory supply. It forms part of our Reversed-Phase Columns range.

pharmaceutical and life-science laboratories depend on well-specified Reversed-Phase Columns products to keep analytical results accurate and repeatable. Technical details include:

• Part number: PL-NSK089J046250
• Internal diameter: 4.5999999999999996 mm
• Particle size: 5µm
• Pore size: 300 Å
• Column type: HPLC Column
• Phase name: Nucleosil 300 C8
• Separation mode: Reversed-Phase
• Column length: 250 mm

These details help you confirm compatibility with your existing setup before ordering. Laboratories rely on Reversed-Phase Columns products for consistent, repeatable results in day-to-day work. The Nucleosil 300 C8 5µm, 250 x 4.6 , HPLC Column is chosen where dependable performance and correct fit are essential, helping to maintain reliable results throughout a workflow.

If you are unsure which Reversed-Phase Columns option matches your requirements, our team can compare specifications and suggest suitable equivalents. Each listing is drawn from trusted suppliers and reviewed for specification accuracy before it reaches our catalogue. We can source alternative configurations and associated Reversed-Phase Columns consumables, and offer bulk pricing where required.

As a UK-based supplier, Picolab Technologies combines a broad Reversed-Phase Columns catalogue with responsive service, helping laboratories obtain what they need without long lead times. Full product data and datasheets can be provided on request to support your qualification and validation records. Orders ship nationwide, and our team can advise on lead times, equivalents, and technical fit.

For current pricing, availability, or advice on whether the Nucleosil 300 C8 5µm, 250 x 4.6 , HPLC Column suits your application, please contact our team.